nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accelerating bioprocess development by analysis of all available data: A USP case study
|
Suarez-Zuluaga, Diego A. |
|
|
37 |
47 |
p. 7081-7089 |
artikel |
2 |
Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media
|
Rourou, Samia |
|
|
37 |
47 |
p. 6987-6995 |
artikel |
3 |
A flow cytometric granularity assay for the quantification of infectious virus
|
Logan, Megan |
|
|
37 |
47 |
p. 7090-7099 |
artikel |
4 |
Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization
|
Stark, Felicity C. |
|
|
37 |
47 |
p. 7108-7116 |
artikel |
5 |
Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF
|
Venereo-Sánchez, Alina |
|
|
37 |
47 |
p. 7100-7107 |
artikel |
6 |
Defining the multiplicity and time of infection for the production of Zaire Ebola virus-like particles in the insect cell-baculovirus expression system
|
Pastor, Ana Ruth |
|
|
37 |
47 |
p. 6962-6969 |
artikel |
7 |
Development of suspension adapted Vero cell culture process technology for production of viral vaccines
|
Shen, Chun Fang |
|
|
37 |
47 |
p. 6996-7002 |
artikel |
8 |
Editorial Board/Aims and Scope
|
|
|
|
37 |
47 |
p. IFC |
artikel |
9 |
Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1
|
Gränicher, Gwendal |
|
|
37 |
47 |
p. 7019-7028 |
artikel |
10 |
Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen
|
Haq, Kamran |
|
|
37 |
47 |
p. 7029-7040 |
artikel |
11 |
Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems
|
Coronel, Juliana |
|
|
37 |
47 |
p. 7011-7018 |
artikel |
12 |
Polymer-grafted chromatography media for the purification of enveloped virus-like particles, exemplified with HIV-1 gag VLP
|
Pereira Aguilar, Patricia |
|
|
37 |
47 |
p. 7070-7080 |
artikel |
13 |
Process intensification for Peste des Petites Ruminants Virus vaccine production
|
Sousa, Marcos |
|
|
37 |
47 |
p. 7041-7051 |
artikel |
14 |
Purification of flavivirus VLPs by a two-step chomatographic process
|
Lima, Túlio M. |
|
|
37 |
47 |
p. 7061-7069 |
artikel |
15 |
Purification of rabies virus produced in Vero cells grown in serum free medium
|
Trabelsi, Khaled |
|
|
37 |
47 |
p. 7052-7060 |
artikel |
16 |
Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development
|
Chen, Ting-Hsuan |
|
|
37 |
47 |
p. 6933-6941 |
artikel |
17 |
Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge
|
Lehrer, Axel T. |
|
|
37 |
47 |
p. 6942-6950 |
artikel |
18 |
Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production
|
Bissinger, Thomas |
|
|
37 |
47 |
p. 7003-7010 |
artikel |
19 |
Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components
|
Fedosyuk, Sofiya |
|
|
37 |
47 |
p. 6951-6961 |
artikel |
20 |
Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification
|
Gerritzen, Matthias J.H. |
|
|
37 |
47 |
p. 6978-6986 |
artikel |
21 |
The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses
|
Tzeng, Tsai-Teng |
|
|
37 |
47 |
p. 7117-7122 |
artikel |
22 |
Vaccine Technology VII: Beyond the “decade of vaccines”
|
Kamen, Amine A. |
|
|
37 |
47 |
p. 6931-6932 |
artikel |
23 |
Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform
|
Alvim, Renata G.F. |
|
|
37 |
47 |
p. 6970-6977 |
artikel |